May 2026
The global large molecule drug discovery outsourcing market size was evaluated at USD 3.20 billion in 2025 and is predicted to hit around USD 7.67 billion by 2035, growing at a CAGR of 9.14%.
June 2026
The global drug discovery outsourcing market size was valued at USD 4.45 billion in 2025 and is projected to hit around USD 8.98 billion by 2035 with a CAGR of 7.27%.
April 2026
The global cancer immunotherapy drug discovery outsourcing market size is expected to hit around USD 4.19 billion by 2035 from USD 1.66 billion in 2025, with a CAGR of 9.70%.
January 2026
The global small molecule drug discovery market size is calculated at USD 95.63 billion in 2025 and is projected to hit around USD 204.06 billion by 2035 with a CAGR of 7.87%.
June 2026
The drug discovery services market size was estimated at USD 24.26 billion in 2025 and is expected to hit around USD 89.58 billion by 2035, growing at a CAGR of 13.95% from 2026 to 2035.
June 2026
The global biomarker discovery outsourcing services market size is evaluated at USD 17.42 billion in 2025 and is predicted to hit around USD 99.38 billion by 2035, growing at a CAGR of 19.02%.
June 2026
The global CNS drug discovery market size was evaluated at USD 9.80 billion in 2025 and is predicted to hit around USD 27.55 billion by 2035, growing at a CAGR of 10.90%.
June 2026
The global drug discovery market size was evaluated at USD 71.89 billion in 2025 and is projected to hit around USD 171.36 billion by 2035 with a CAGR of 9.07%.
June 2026
The US drug discovery market size was evaluated at USD 26.24 billion in 2025 and is predicted to hit around USD 63.02 billion by 2035, growing at a CAGR of 9.16%.
May 2026
The global in-silico drug discovery market size is estimated to hit around USD 11.8 billion by 2035 increasing from USD 4.17 billion in 2025, with a CAGR of 10.96%.
May 2026
The global computational medicine and drug discovery software market size was evaluated at USD 10.90 billion in 2025 and is predicted to hit around USD 60.52 billion by 2035, growing at a CAGR of 18.70%.
April 2026
The global drug discovery informatics market size is estimated at USD 4.81 billion in 2025 and is projected to surpass around USD 13.68 billion by 2035 at a CAGR of 11.02%.
March 2026
The global computer-aided drug discovery market size is projevted to hit around USD 14.38 billion by 2035 from USD 4.72 billion in 2025 with a CAGR of 11.78%.
February 2026
The global gastro-retentive drug delivery systems outsourcing market size is expected to increase from USD 2.04 billion in 2025 to hit around USD 3.86 billion by 2035, growing at a CAGR of 6.58%.
January 2026
The generative AI in drug discovery market size reached USD 260.56 million in 2025 and is estimated to hit around USD 2,724.15 million by 2035, at a CAGR of 26.45%.
November 2025
The artificial intelligence (AI) in drug discovery market size is predicted to surpass around USD 17.81 billion by 2035 from USD 6.93 billion in 2025 with a solid CAGR of 9.90%.
September 2025
The AI-driven drug discovery platforms market is growing as pharmaceutical companies leverage AI to accelerate target identification and lead optimization.
August 2025
The U.S. pharmaceutical CDMO market size was calculated at USD 40.52 billion in 2024 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
August 2025
The global pharmaceutical CRO market size was evaluated at USD 44.58 billion in 2024 and is projected to attain around USD 91.20 billion by 2034, with a CAGR of 7.42%.
June 2026
The global laboratory products and outsourcing services market size is estimated at USD 41.78 billion in 2025 and is expected to hit around USD 91.45 billion by 2035, growing at a CAGR of 8.15%
June 2026
The global small molecule innovator CDMO market size is valued at USD 56.41 billion in 2025 and is projected to hit around USD 103.22 billion by 2035 with a CAGR of 6.23%.
June 2026
The global synthetic small molecule API market size is estimated to hit around USD 342.63 billion by 2035 increasing from USD 197.21 billion in 2025, with a CAGR of 5.68%.
June 2026
The global topical drug delivery market size was valued at USD 136.35 billion in 2025 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
June 2026
The U.S. multiple sclerosis drugs market size is estimated to hit around USD 18.43 billion by 2035 increasing from USD 8.44 billion in 2025, with a CAGR of 8.12%.
June 2026
The global non-alcoholic fatty liver disease (NAFLD) drug market size is estimated to hit around USD 35.10 billion by 2035 from USD 21.98 billion in 2025, with a CAGR of 4.79%.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
The global rheumatoid arthritis drugs market size was valued at USD 64.35 billion in 2025 and is expected to hit around USD 76.83 billion by 2035, growing at a CAGR of 1.79% from 2026 to 2035.
June 2026
The global sarcoidosis drug market size was estimated at USD 8.82 billion in 2025 and is expected to hit around USD 15.93 billion by 2035, growing at a CAGR of 6.09%.
June 2026
The global lyophilized oncology drug market size is growing as demand increases for stable, long-lasting cancer formulations and advanced freeze-drying technologies.
June 2026
The global PD-1 inhibitor drugs market size was estimated at USD 48.69 billion in 2025 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com